Acuson's long-suffering stock price got a big boost this monthafter an analyst at Morgan Stanley raised his rating of the stockfrom "neutral" to "outperform."The Mountain View, CA, ultrasound vendor's stock leaped 31%the week of Sept.
Acuson's long-suffering stock price got a big boost this monthafter an analyst at Morgan Stanley raised his rating of the stockfrom "neutral" to "outperform."
The Mountain View, CA, ultrasound vendor's stock leaped 31%the week of Sept. 9, from $13.63 on Sept. 8, the day before therating was issued, to $17.88 at the end of the week. It was tradingat around $17.50 last week.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
Breast MRI and Background Parenchymal Enhancement: What a Meta-Analysis Reveals
May 29th 2025Moderate or marked background parenchymal enhancement (BPE) reduces the sensitivity and specificity of MRI for breast cancer detection by more than 10 percent in comparison to scans with minimal or mild BPE, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
2 Commerce Drive
Cranbury, NJ 08512